NCT06517927Recruiting
Prevalence of Long-term Dental Effects of Chemotherapy in Childhood Cancer Survivors Diagnosed With Cancer Before the Age of 10
Source: ClinicalTrials.gov · Last updated 19 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To date, there are no methods for assessing the risk of oral developmental defects that could predict long-term adverse effects in childhood cancer survivors. Having such a method at our disposal would enable us to better assess the risk to develop those defects and will help us provide new prevention and treatment strategies to ensure a healthy oral development. The aims of this study are : * Assess the caries risk in childhood cancer survivors compared with a control group. * Assess the dental development defects risk in childhood cancer survivors compared with a control group.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 142 (estimated)
- First submitted
- 18 Jul 2024
- Start date
- 3 May 2024
- Primary completion date
- 3 May 2026
- Lead sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Diseases
- Childhood cancers
- NCT number
- NCT06517927
What you commit to
- Study type: Interventional
- Planned participants: 142
- From 3 May 2024 to the primary completion date, 3 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with syndrome or diseases that involve teeth impairment\*
Age
- A patient who was diagnosed and treated after 10 years old.
- Patient below 12 years old at time of study recruitment
Other
- Pregnant patient
- Refusal or inaptitude to undergo dental and radiographic examination
Who the study is looking for
- age below 10 at cancer diagnosis (for the CCS group).
- Chemotherapy must have been used to treat the patient (For the CCS group).
- The patient is 12 years old or older at the time of the follow-up appointment of the present study
Age in the registry: 12 years to 36 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cliniques universitaires Saint-Luc Coordinator of this site? Confirm its status | Brussels | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.